Long-Term Safety of Certolizumab Pegol in Plaque Psoriasis: Pooled Analysis over 3 Years from Three Phase 3, Randomized, Placebo-Controlled Studies. J of Skin. 2020;4(5):s46. doi:10.25251/skin.4.supp.46